Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNK | O75909 | 19/20 | 0.86 |
| ▸ | CDK12 | Q9NYV4 | 19/20 | 0.86 |
| ▸ | CCNT1 | O60563 | 16/20 | 0.86 |
| ▸ | CCNE1 | P24864 | 16/20 | 0.86 |
| ▸ | CDK2 | P24941 | 16/20 | 0.86 |
| ▸ | CDK9 | P50750 | 16/20 | 0.86 |
| ▸ | CDK7 | P50613 | 13/20 | 0.86 |
| ▸ | CCNH | P51946 | 13/20 | 0.86 |
| ▸ | MNAT1 | P51948 | 7/20 | 0.86 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sy-5609 SCHEMBL29855824 | 0.93 | CDK7 (1.00) | CCNKCDK12CCNT1CCNE1CDK2 | |
| Sy-5609 SCHEMBL22076285 | 0.93 | CDK7 (1.00) | CCNKCDK12CCNT1CCNE1CDK2 | |
| Sy-5609 SCHEMBL22076284 | 0.93 | CDK7 (1.00) | CCNKCDK12CCNT1CCNE1CDK2 | |
| SCHEMBL25593099 | 0.89 | CCNK (0.85) | CCNKCDK12CCNT1CCNE1CDK2 | |
| SCHEMBL22076296 | 0.88 | CCNK (0.79) | CCNKCDK12CCNT1CCNE1CDK2 | |
| SCHEMBL22076294 | 0.88 | CCNK (0.79) | CCNKCDK12CCNT1CCNE1CDK2 | |
| SCHEMBL25597569 | 0.87 | CCNK (0.77) | CCNKCDK12CCNT1CCNE1CDK2 | |
| SCHEMBL25593057 | 0.86 | CCNK (0.76) | CCNKCDK12CCNT1CCNE1CDK2 | |
| SCHEMBL25597608 | 0.85 | CCNK (0.75) | CCNKCDK12CCNT1CCNE1CDK2 | |
| SCHEMBL25593809 | 0.85 | CDK7 (0.86) | CCNKCDK12CCNT1CCNE1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022082056-A1 | DOSING REGIMENS FOR CYCLIN‑DEPENDENT KINASE 7 (CDK7) INHIBITORS | SYROS PHARMACEUTICALS, INC. (US) | 2022-04-21 | — | — | WO | disclosed |